11.05.2016
- Israel-based Teva, the world's largest generic drugmaker, still expects its $40.5 billion acquisition of Allergan's generics business, which trades as Actavis, to close in June...
07.04.2016
- The targeted $160 billion merger between Pfizer and Allergan has run afoul of new anti-inversion legislation proposed by the US Treasury, as had been predicted by most deal...
06.04.2016
- What a difference a day makes. On Apr. 3, European time, Pfizer and Allergan said the US Federal Trade Commission’s deeper probe into their potential merger, the so-called second...
16.02.2016
- US drugmaker Eli Lilly has lost the latest round in an ongoing legal fight in the UK over patents relating to the administration of vitamins given alongside its blockbuster lung...
15.02.2016
- Major UK drugs firm GlaxoSmithKline (GSK) has been fined more than £37 million by the Competition and Markets Authority (CMA) for anti-competitive behavior relating to generic...
30.10.2015
- US pharmaceutical giant Pfizer and Ireland-domiciled former US drugmaker Allergan (in its current incarnation a combined Allergan and Actavis) have confirmed they are in “friendly”...
07.10.2015
- The pharmaceutical industry is entering a period of sustained growth. Prescription drug sales are set to advance at almost 5% a year until 2020, while worldwide prescription drug...
30.07.2015
- July this year began with the highest-ever value of M&A transactions announced in any July since 2008, says Mergermarket, an independent Mergers and Acquisitions (M&A) intelligence...
